FMC WKN: 871138 ISIN: US3024913036 Kürzel: FMC Forum: Aktien Thema: Hauptdiskussion

Moin moin bin nun auch dabei.

3 CEOs Just Spent Millions Buying Their Beaten-Down Stock By Ed Lin March 09, 2025, 3:00 am EDT FMC Chairman and CEO Pierre R. Brondeau paid $1.9 million on March 4 for 54,000 shares of the agricultural-sciences firm, an average price of $35.90 each. He now owns 298,439 FMC shares. FMC shares tumbled in early February after the company provided an outlook that fell short of analyst expectations. “My recent purchase of nearly $2 million in FMC shares reflects my personal confidence in our company’s strategy and future,” Brondeau wrote in an email in response to a request for comment. “The current share price presented what I view as a compelling opportunity to increase my personal investment in a company whose short-term and long-term prospects I firmly believe in.” https://www.barrons.com/articles/ceo-stock-buys-moderna-fmc-akamai-f1373290?mod=mw_quote_news&adobe_mc=MCMID%3D14605416935782053551746103278121613868%7CMCORGID%3DCB68E4BA55144CAA0A4C98A5%2540AdobeOrg%7CTS%3D1783674581

FMC Advances Regulatory Submission for Innovative Herbicide Rimisoxafen GuruFocus News 07/08/2026 22:51 On July 08, 2026, FMC has officially submitted its regulatory dossier for rimisoxafen to the U.S. Environmental Protection Agency (EPA), marking a significant milestone as it represents the first such submission worldwide for this novel herbicide ingredient. This filing includes its application on crops such as corn, soybean, sunflower, and select pulse varieties. What's Behind the News? The submission of the regulatory dossier for rimisoxafen is a pivotal development for FMC Corp, as it showcases the company's commitment to innovation in the agricultural sector. Rimisoxafen, developed at FMC's Stine Research Center, is distinguished by its dual mode of action, which targets two separate biochemical pathways in weeds. This innovative approach aims to mitigate the risk of herbicide resistance, a growing concern in modern agriculture. The significance of this submission is amplified by the fact that it is the first of its kind globally, positioning FMC as a leader in herbicide development.

Gemini: Ups, von 17 auf 12 Dollar. Warum, wo doch die Schuldenreduzierung um 1 Milliarde Dollar bereits erreicht wurde?: UBS analysts maintain a Neutral rating on FMC Corporation (NYSE: FMC) with a price target raised to $17.00 (from $14.00). The cautious valuation reflects headwinds from declining crop chemical demand, inventory destocking, and ongoing pressure on earnings, despite the company's aggressive restructuring efforts like selling its India commercial business.Analyst Consensus & TargetUBS Rating: NeutralUBS Price Target: $17.00 (up from $14.00)Consensus Rating: HoldConsensus Average Target: ~$13.00 to $16.52Key Drivers Behind the AnalysisMarket Headwinds: A prolonged downturn in crop protection markets and weak demand volumes have significantly impacted FMC's sales trajectory.Financial Pressures: Consecutive years of subdued EBITDA, elevated debt levels, and the suspension of dividends have weighed heavily on investor sentiment.Restructuring & Debt Reduction: To counter declining cash flows, FMC agreed to sell its India commercial business and set aggressive targets to pay down $1 billion in debt.Strategic Pivot: Shifts toward a direct-to-farm sales model—particularly in complex markets like Brazil—add near-term execution risks to their delivery and cost-reduction plans.

UBS Sticks to Its Hold Rating for FMC (FMC) TipRanks Auto-Generated Intelligence Newsdesk Jul 06, 2026, 10:26 AM UBS Sticks to Its Hold Rating for FMC (FMC) UBS analyst Joshua Spector maintained a Hold rating on FMC today and set a price target of $12.00.

Ja 1883 Stück in 2 mal. Erstens über 12 $ und am nächten Tag nochmals wenn es herunter ging. KGV 11.61 $

Hast du zugegriffen?

Luc Tack von Tessenderlo ist bekannt für sein Gespür für angeschlagene Unternehmen. Er bleibt langfristiger Anteilseigner, um die Firma wieder auf Kurs zu bringen. Dasselbe tat er bereits mit Picanol-Webstühlen. Seine Holdinggesellschaft verfügt über eine Agrarsparte, und er ist an den neuen Molekülen von FMC interessiert.

Equity issuance: also neue Aktien. FMC price target lowered to $14 from $15 at BMO Capital TheFly Jul 03, 2026, 01:15 PM BMO Capital lowered the firm’s price target on FMC (FMC) to $14 from $15 and keeps a Market Perform rating on the shares. The firm cites the company’s $400M equity raise to Tessenderlo for the target cut. While the equity issuance wasn’t expected, it allows FMC to stabilize the balance sheet and change the focus to holding EBITDA at $700M, the analyst tells investors in a research note.

Ich weiss nicht warum aber ich muss hier zu 9,6€ einfach zugreifen

Ich war mal so frei deine Frage der KI zu stellen, Antwort: Ja, genau. Es handelt sich hierbei um eine sogenannte Sachkapitalerhöhung bzw. ein Private Placement (eine Privatplatzierung). FMC gibt im Rahmen dieser Vereinbarung exakt 30.319.166 Stammaktien komplett neu aus, die direkt an die Tessenderlo Group gehen. Die direkten Folgen: Frisches Kapital fließt dem Unternehmen zu: Weil die Aktien neu geschaffen werden, fließen die rund 403 Millionen US-Dollar direkt auf das Bankkonto von FMC (und werden nicht an andere Aktionäre gezahlt, wie es beim Kauf über die normale Börse der Fall wäre). FMC nutzt dieses frische Geld, um Schulden zu tilgen. Verwässerung für Altaktionäre: Da sich die Gesamtzahl aller ausstehenden FMC-Aktien durch die Neuemission erhöht, verwässert sich der prozentuale Anteil der bisherigen Aktionäre am Unternehmen um die entsprechenden 20 %.

Frage: Bedeutet das die Ausgabe neuer Aktien und damit eine Verwässerung? Oder werden hier bestehende Aktien gekauft? Ich nehme Ersteres an, sonst würde es ja keine Einnahmen für FMC generieren.

Tessenderlo Group Invests $400M in FMC (FMC) to Enhance Shareholding GuruFocus News 07/01/2026 12:26 On July 01, 2026, FMC Corporation announced a definitive agreement with Tessenderlo Group for a significant minority equity investment valued at around $400 million, priced at $13.30 per share. Following the completion of this transaction, Tessenderlo Group will hold approximately 20% of FMC’s total outstanding shares. This strategic move marks the conclusion of a review process conducted by FMC's Board of Directors that began in February, aimed at evaluating potential options for the company. What's Behind the News? The recent agreement between FMC Corporation and Tessenderlo Group represents a significant strategic maneuver aimed at bolstering FMC's financial position. The $400 million investment is expected to be primarily directed towards reducing FMC's debt, which is crucial for the company's long-term sustainability. The Board of Directors' review process, which began in February, reflects a proactive approach to addressing financial challenges and exploring avenues for growth.

"FMC und Corteva schließen strategische Partnerschaft für Herbizid-Technologie" https://de.investing.com/news/company-news/fmc-und-corteva-schliesen-strategische-partnerschaft-fur-herbizidtechnologie-93CH-3526061

Stand vor 20 Jahren

https://www.cnbc.com/quotes/FMC?qsearchterm= Und noch weiter. Am Ende. Vorbei. Durch.